anayamalik, Author at European Medical Journal - Page 79 of 120

RSV Co-Infections Drive ICU Admissions in Hospitalized Children

Respiratory syncytial virus (RSV) remains a leading cause of pediatric respiratory infections, with a new study highlighting its widespread co-infections and severe clinical outcomes in hospitalized children.

How Juvenile Arthritis Disrupts Puberty in Children

Children with juvenile idiopathic arthritis (JIA) face more than just joint pain, emerging research reveals that the condition may significantly delay puberty.

New Ultrasound Treatment Significantly Reduces Acne Scars

A novel high-intensity, high-frequency ultrasound device has demonstrated significant effectiveness in reducing facial acne scars, according to a new clinical study.

Sex-Specific Heart Risks: Muscle Strength Matters

A study using machine learning has identified dynapenia, age-related muscle weakness, as a critical but overlooked risk factor for atherosclerotic cardiovascular disease (ASCVD), particularly in females.

Transforming Clinical Trials to Fast-Track Cancer Immunotherapy

Discover how SITC’s innovative strategies are transforming clinical trials to accelerate the development and approval of cancer immunotherapies, aiming for 100 new treatments in the next decade.

To What Extent Can a Smartphone App Help Pregnant Smokers Quit?

A groundbreaking new study is testing an AI-powered smartphone app designed to help pregnant smokers quit, leveraging social support and adaptive reinforcement learning to improve outcomes.

Smarter Screening: Using AI To Identify TB Risk in HIV

A new machine learning model predicts active tuberculosis in people with HIV more accurately than current tests, offering a promising tool for early intervention and preventive treatment.

Adipose Stem Cells: Transforming Care in Systemic Sclerosis

Adipose-derived stem cells (ADSCs) may offer a groundbreaking new approach to treating systemic sclerosis (SSc), according to a recent study.

Blood Plasma in Wound Healing: Breakthrough or Hurdle?

Blood plasma, fibrinogen, and fibrin have long been explored for their role in skin tissue engineering and dermatological treatments, with promising preclinical results—but clinical adoption remains limited.

School-Based Rebound Therapy for Improved Chest Health in Children

A recent study explores the potential of school-based rebound therapy to improve chest health, motor function, and quality of life in children with neurodisability and respiratory issues.